Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUVOREXANT vs TAFAMIDIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUVOREXANT vs TAFAMIDIS: Safety Overview

Metric SUVOREXANT TAFAMIDIS
Total FAERS Reports 9,413 9,202
Deaths Reported 219 3,343
Death Rate 2.3% 36.3%
Hospitalizations 572 2,284
Average Patient Age 62.6 yrs 80.7 yrs
% Female Patients 62.4% 20.7%
FDA Approval Date Aug 13, 2014 May 3, 2019
Manufacturer Merck Sharp & Dohme LLC Pfizer Laboratories Div Pfizer Inc
Route ORAL N/A
Marketing Status Prescription Prescription